Geron
GERN
#7199
Rank
C$0.84 B
Marketcap
C$1.31
Share price
-7.86%
Change (1 day)
-13.73%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -C$26.03 Million

According to Geron's latest financial reports the company's current earnings are C$0.21 Billion. In 2025 the company made an earning of -C$72.87 Million, an increase over its 2024 earnings that were of -C$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$26.03 Million-64.29%
2025 -C$72.87 Million-67.42%
2024 -C$0.23 Billion-11.23%
2023 -C$0.26 Billion30.22%
2022 -C$0.2 Billion20.15%
2021 -C$0.17 Billion50.08%
2020 -C$0.11 Billion4.46%
2019 -C$0.11 Billion130.68%
2018 -C$44.54 Million8.84%
2017 -C$40.92 Million-3.08%
2016 -C$42.22 Million-22080.6%
2015 C$0.19 M-100.38%
2014 -C$51.01 Million-7.14%
2013 -C$54.93 Million
2011 -C$0.13 Billion19.04%
2010 -C$0.11 Billion8.45%
2009 -C$0.11 Billion-2.51%
2008 -C$0.11 Billion14.65%
2007 -C$90.06 Million32.68%
2006 -C$67.88 Million25.59%
2005 -C$54.05 Million4.36%
2004 -C$51.79 Million19.73%
2003 -C$43.26 Million-15.46%
2002 -C$51.17 Million1.94%
2001 -C$50.19 Million33.59%
2000 -C$37.57 Million27.53%
1999 -C$29.46 Million63.13%
1998 -C$18.06 Million15.6%
1997 -C$15.63 Million-10.66%
1996 -C$17.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-C$3.64 Billion 13,205.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
C$1.14 B-4,282.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-C$99.23 Million 263.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.35 B-1,414.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$23.68 Million-13.22%๐Ÿ‡บ๐Ÿ‡ธ USA